<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Choice and medication</title>
	<link>http://choiceandmedication.org/cms</link>
	<description>Quality assured information about medications used in the mental health setting to help people make informed decisions</description>
	<lastBuildDate>Wed, 16 Nov 2011 12:57:05 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>Citalopram top doses reduced</title>
		<description><![CDATA[At the end of October 2011, the UK MHRA reduced the top doses of citalopram that are recommended.]]></description>
		<link>http://choiceandmedication.org/cms/2011/11/citalopram-top-doses-reduced/</link>
			</item>
	<item>
		<title>Citalopram and heart rhythms</title>
		<description><![CDATA[The Americans have recommended that citalopram is not used at doses above 40mg a day. ]]></description>
		<link>http://choiceandmedication.org/cms/2011/08/citalopram-and-heart-rhythms/</link>
			</item>
	<item>
		<title>Asenapine (Saphris)</title>
		<description><![CDATA[Asenapine licensed in Europe for mania. ]]></description>
		<link>http://choiceandmedication.org/cms/2011/07/asenapine-saphris/</link>
			</item>
	<item>
		<title>Research helping to reduce inappropriate prescribing of antipsychotics</title>
		<description><![CDATA[Studies into depression and agitation and aggression will play a key role in helping to reduce inappropriate prescriptions of antipsychotics for people with dementia. ]]></description>
		<link>http://choiceandmedication.org/cms/2011/07/research-helping-to-reduce-inappropriate-prescribing-of-antipsychotics/</link>
			</item>
	<item>
		<title>Antidepressant use in women</title>
		<description><![CDATA[Platform 51 (what used to be WYCA) have published a report in July 2011 about the use of antidepressants in women, especially in people taking them for many years.]]></description>
		<link>http://choiceandmedication.org/cms/2011/07/antidepressant-use-in-women/</link>
			</item>
	<item>
		<title>Call to action: the use of antipsychotic drugs for people with dementia</title>
		<description><![CDATA[The NHS Institute for Innovation and Improvement and the Dementia Action Alliance have launched a call to action to work together to improve the quality of life of people with dementia and their carers by reducing the inappropriate use of antipsychotics for these people.]]></description>
		<link>http://choiceandmedication.org/cms/2011/06/call-to-action-the-use-of-antipsychotic-drugs-for-people-with-dementia/</link>
			</item>
	<item>
		<title>Paliperidone depot injection (Xeplion®) launched</title>
		<description><![CDATA[A long-acting depot injection (once-a-month) became available in April 2011 in the UK. ]]></description>
		<link>http://choiceandmedication.org/cms/2011/04/paliperidone-depot-injection-xeplion%c2%ae-launched/</link>
			</item>
	<item>
		<title>PCT prescribing data January to March 2011</title>
		<description><![CDATA[This dataset from the NHS Information Centre provides information about Primary Care Trust (PCT) prescribing data between January and March 2011.]]></description>
		<link>http://choiceandmedication.org/cms/2011/04/pct-prescribing-data-january-to-march-2011/</link>
			</item>
	<item>
		<title>NICE guidelines on Alzheimer’s Disease</title>
		<description><![CDATA[NICE has reviewed and re-appraised the main drugs used for the treatment of Alzheimer’s disease: donepezil, galantamine, rivastigmine and memantine.]]></description>
		<link>http://choiceandmedication.org/cms/2011/03/nice-guidelines-on-alzheimer%e2%80%99s-disease/</link>
			</item>
	<item>
		<title>Professor Bazire explains the aims of the Choice and medication website</title>
		<description><![CDATA[In this video Professor Steve Bazire, MBE, Director, Mistura Enterprise explains the aims of the Choice and medication website.]]></description>
		<link>http://choiceandmedication.org/cms/2010/11/professor-bazire-explains-the-aims-of-the-choice-and-medication-website/</link>
			</item>
	<item>
		<title>Olanzapine depot injection (Zypadhera®) launched</title>
		<description><![CDATA[Olanzapine is available as tablets, melt-in-the-mouth tablets, a short-acting injection and now as a depot (or long-acting) injection (called Zypadhera®). ]]></description>
		<link>http://choiceandmedication.org/cms/2010/07/olanzapine-depot-injection-zypadhera%c2%ae-launched/</link>
			</item>
	<item>
		<title>Agomelatine (Valdoxan®) launched UK 2009</title>
		<description><![CDATA[Agomelatine is commonly known by the brand name Valdoxan® in the UK and was first made available in 2009.]]></description>
		<link>http://choiceandmedication.org/cms/2009/10/agomelatine-valdoxan%c2%ae-launched-uk-2009/</link>
			</item>
	<item>
		<title>Consultation on the proposed framework for Quality Accounts</title>
		<description><![CDATA[The Department of Health has launched a public consultation on the proposed framework for Quality Accounts.]]></description>
		<link>http://choiceandmedication.org/cms/2009/09/consultation-on-the-proposed-framework-for-quality-accounts/</link>
			</item>
	<item>
		<title>Videos to support the implementation of NICE guidance on personality disorder</title>
		<description><![CDATA[The Department of Health have produced videos to support the implementation of NICE guidance on Borderline Personality Disorder and Antisocial Personality Disorder.]]></description>
		<link>http://choiceandmedication.org/cms/2009/09/videos-to-support-the-implementation-of-nice-guidance-on-personality-disorder/</link>
			</item>
	<item>
		<title>Mental Health First Aid guidelines</title>
		<description><![CDATA[The Mental Health First Aid guidelines contain information about how a member of the community can give initial help to  someone who they think might be developing or experiencing a mental illness or a mental health crisis.]]></description>
		<link>http://choiceandmedication.org/cms/2009/09/mental-health-first-aid-guidelines/</link>
			</item>
	<item>
		<title>Consultation on adult acute mental health units guidance</title>
		<description><![CDATA[The Department of Health is developing new guidance on adult acute mental health units and are seeking your views on the latest draft.]]></description>
		<link>http://choiceandmedication.org/cms/2009/08/consultation-on-adult-acute-mental-health-units-guidance/</link>
			</item>
	<item>
		<title>Care Quality Commission consultation</title>
		<description><![CDATA[The Care Quality Commission is seeking your views on a strategy for its work on mental health over the next three to five years.]]></description>
		<link>http://choiceandmedication.org/cms/2009/08/care-quality-commission-consultation/</link>
			</item>
	<item>
		<title>New Horizons: towards a shared vision for mental health &#8211; consultation</title>
		<description><![CDATA[‘New Horizons’ marks a new era in mental health. It sets out a dynamic new approach to improving well-being for the whole population, aiming for the first time to create a powerful alliance that can target the root causes of poor mental health.]]></description>
		<link>http://choiceandmedication.org/cms/2009/07/new-horizons-towards-a-shared-vision-for-mental-health-consultation/</link>
			</item>
	<item>
		<title>Building a society for all ages: Choice for older people</title>
		<description><![CDATA[The Government has launched a strategy “Building A Society For All Ages”, to help Britain prepare for our ageing society. ]]></description>
		<link>http://choiceandmedication.org/cms/2009/07/building-a-society-for-all-ages-choice-for-older-people/</link>
			</item>
</channel>
</rss>

